KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Capital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresLong-Term Debt IssuancesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CRISPR Therapeutics AG (CRSP) Cash from Investing Activities (2016 - 2026)

CRISPR Therapeutics AG (CRSP) has disclosed Cash from Investing Activities for 11 consecutive years, with $37.2 million as the latest value for Q4 2025.

  • Quarterly Cash from Investing Activities fell 64.85% to $37.2 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$31.8 million through Dec 2025, up 88.66% year-over-year, with the annual reading at -$31.8 million for FY2025, 88.66% up from the prior year.
  • Cash from Investing Activities hit $37.2 million in Q4 2025 for CRISPR Therapeutics AG, up from -$119.2 million in the prior quarter.
  • In the past five years, Cash from Investing Activities ranged from a high of $216.9 million in Q2 2023 to a low of -$565.2 million in Q3 2021.
  • Historically, Cash from Investing Activities has averaged -$61.6 million across 5 years, with a median of -$68.8 million in 2022.
  • Biggest five-year swings in Cash from Investing Activities: crashed 8045.24% in 2021 and later soared 486.87% in 2023.
  • Year by year, Cash from Investing Activities stood at -$8.7 million in 2021, then tumbled by 1913.91% to -$175.5 million in 2022, then soared by 53.6% to -$81.5 million in 2023, then skyrocketed by 229.93% to $105.8 million in 2024, then tumbled by 64.85% to $37.2 million in 2025.
  • Business Quant data shows Cash from Investing Activities for CRSP at $37.2 million in Q4 2025, -$119.2 million in Q3 2025, and $70.0 million in Q2 2025.